Medication info
Pharmagen Tablets (Famotidine)

Pharmagen Tablets (Famotidine)

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
(Stock Company) Ilhwa
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 198700535 · Notified 1987.01.20 · Insurance code 640901210

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers); preanesthetic medication; improvement of gastric mucosal lesions and bleeding
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine orally at a dose of 20mg twice daily (after breakfast and dinner, or at bedtime), or 40mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection, and changed to oral administration once oral administration becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10mg twice daily (after breakfast and dinner, or at bedtime), or 20mg once daily (at bedtime). The dose may be adjusted according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine in 20ml of normal saline injection or glucose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, efficacy is generally seen within 1 week. Once oral administration becomes possible, change to oral administration. When used for preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer by intramuscular injection 1 hour before induction of anesthesia, or dissolve it in 20ml of normal saline injection or glucose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or under refrigeration. The dose may be adjusted according to age and symptoms.

Ingredients

Manufacturer
(Stock Company) Ilhwa

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers); preanesthetic medication; improvement of gastric mucosal lesions and bleeding

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal erythema
  • gastric mucosal edema
View approved original text

This medication is primarily used to treat ulcers occurring in the stomach and duodenum, as well as anastomotic ulcers. It is also effective in improving inflammation and damage of the gastric mucosa in cases of upper gastrointestinal bleeding or acute exacerbation of acute and chronic gastritis. When taken orally, it is effective for gastritis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. When administered intravenously, it is used for the treatment of acute peptic ulcer bleeding, acute stress ulcers, hemorrhagic gastritis, and for prophylaxis before anesthesia. In short, this drug helps alleviate symptoms of various gastrointestinal disorders and improves mucosal condition, thereby enhancing the digestive health of patients.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults: Administer famotidine orally at a dose of 20mg twice daily (after breakfast and dinner, or at bedtime), or 40mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection, and changed to oral administration once oral administration becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10mg twice daily (after breakfast and dinner, or at bedtime), or 20mg once daily (at bedtime). The dose may be adjusted according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine in 20ml of normal saline injection or glucose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, efficacy is generally seen within 1 week. Once oral administration becomes possible, change to oral administration. When used for preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer by intramuscular injection 1 hour before induction of anesthesia, or dissolve it in 20ml of normal saline injection or glucose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or under refrigeration. The dose may be adjusted according to age and symptoms.

Precautions

This medication should not be used in patients who have an allergy to specific components or have had hypersensitivity to H2 receptor antagonists. This medication contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should not take it. Patients with a history of hypersensitivity, or with kidney, liver, or heart problems should use this medication with caution, and elderly patients require vigilance as well. While rare, serious side effects may occur with this medication, so careful monitoring of one's condition is necessary. Serious allergic reactions, blood abnormalities, skin disorders, liver dysfunction, muscle damage, cardiac rhythm disturbances, kidney problems, and pulmonary diseases may occur, so if any abnormal symptoms arise, the medication should be discontinued immediately and a physician consulted. This medication dissolves in the mouth but is absorbed in the stomach, so it should be swallowed with water or saliva. Regular blood tests, liver function tests, and kidney function tests should be conducted, and the treatment process should be closely monitored. When taken with other medications, the effectiveness may decrease or the risk of side effects may increase, so it is necessary to consult a doctor or pharmacist. Especially, elderly patients may have reduced kidney function and may need dose adjustment. Pregnant women or women who may become pregnant should use this medication with caution, and breastfeeding should be discontinued if nursing. Safety has not been sufficiently established for children, so use is not recommended. Orally disintegrating tablets should be placed on the tongue, allowed to dissolve, and then swallowed, avoiding lying down while taking or taking without water. Symptoms of gastric cancer may be masked by taking this medication, so it should only be used after confirming the malignancy.

Side effects

  • shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • systemic rash
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 82 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • Lyell syndrome
  • liver dysfunction
  • jaundice
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevation of serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • convulsions
  • generalized convulsions
  • interstitial nephritis
  • acute renal failure
  • fever
  • skin rash
  • urticaria
  • erythema
  • facial edema
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • loose stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • liver dysfunction
  • jaundice
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • agitation
  • excitement
  • decreased libido
  • sensory abnormalities
  • heaviness
  • transient confusional state
  • depression
  • convulsions
  • altered consciousness
  • dizziness
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • elevated CK (CPK)
  • altered taste
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius room temperature. Proper storage helps to maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.